Diluted EPS came in at $2.16.
Filings will appear here once submitted to SEC EDGAR.
Common questions about Galmed Pharmaceuticals's Q2 2024 earnings report.
Galmed Pharmaceuticals (GLMD) reported Q2 2024 earnings on August 28, 2024 before market open.
Galmed Pharmaceuticals reported diluted EPS of $2.16 for Q2 2024.